British Columbia Order in Council — Order under Pharmacists, Pharmacy Operations and Drug Scheduling Approving three Resolutions of the Council of the College of Pharmacists of British Columbia amending the Drug Schedules Regulation (O.C. 1627/2000)

O.C. 1627/2000

British Columbia — Orders in Council

PROVINCE OF BRITISH COLUMBIA ORDER OF THE LIEUTENANT GOVERNOR IN COUNCIL Order in Council No. --- 1627 , Approved and Ordered NOV 2 3 2000 Lieutenant Governor Executive Council Chambers, Victoria On the recommendation of the undersigned, the Lieutenant Governor, by and with the advice and consent of the Executive Council, orders that approval be given to the following: (

a) the attached Resolution of the Council of the College of Pharmacists of British Columbia, dated November 26, 1999, amending B.C. Reg 9/98, the Drug Schedules Regulation; (

b) the attached Resolution of the Council of the College of Pharmacists of British Columbia dated February 11, 2000, amending the Drug Schedules Regulation referred to in paragraph (

a) of this Order; and (

c) the attached Resolution of the Council of the College of Pharmacists of British Columbia dated April 14, 2000, further amending the Drug Schedules Regulation referred to in paragraph (

a) of this Order. Minister of Health and Minister Responsible for en (This

part is for administrative purposes only and is not part of the Order) Authority under which Order is made: Pharmacists, Pharmacy Operations and Drug Act and section:- Scheduling Act,

section 64 1368/00/13 Other (specify):- KAPPODSA \Oic.00\orderdiug2.doe

Resolution of the Council of the College of Pharmacists of British Columbia ("the Council"), made at Vancouver, British Columbia, the 14 day of April 2000. RESOLVED THAT: In accordance with the authority established in

Section 64 of The Pharmacists, Pharmacy Operations and Drug Scheduling Act, R.S.B.C. 1996, c. 363 of British Columbia, the Council amends the Drug Schedules Regulation as set out in the attached schedule, subject to the approval of the Lieutenant Governor in Council. Certified a true copy Linda Lytle, B.Sc.( r.), R.Ph., CAE Registrar ()feu-15/11 A AResolution Submission - I0 Isla 2000 dot:

SCHEDULE That, effective immediately, the Drug Schedules Regulation be amended by the addition of 1 Daclizumab 1 Marbofloxacin and its salts and derivatives 1 Melanoma therapeutic vaccine 1 Oseltamivir and its salts 1 Poractant alfa 1 Risedronic acid and its salts 1 Rofecoxib 1 Telmisartan and its salts and derivatives 1 Temozolomide and its salts 1 Tirofiban and its salts and derivatives 1 Trastuzumab oteu-15/1t A:\Resolution Submission - 10 May 2000 doc

Resolution of the Council of the College of Pharmacists of British Columbia ("the Council"), made at Vancouver, British Columbia, the 11 th day of February 2000. RESOLVED THAT: In accordance with the authority established in

Section 64 of The Pharmacists, Pharmacy Operations and Drug Scheduling Act, R.S.B.C. 1996, c. 363 of British Columbia, the Council amends the Drug Schedules Regulation as set out in the attached schedule, subject to the approval of the Lieutenant Governor in Council. Certified a true copy Linda Lytle, B.Sc.( hr.), R.Ph., CAE Registrar oteu- 1 5/1t A'',1 1 1'eh '00 Drug Sch. Reg. Submission. do

SCHEDULE That, effective immediately, the Drug Schedules Regulation be amended by the deletion of: Androisoxazole 1 Androstanolone 1 Androstenediol and its derivatives' 1 Bolandiol and its derivatives 1 Bolasterone 1 Bolazine 1 Boldenone and its derivatives 1 Bolenol 1 Calusterone 1 Clostebol and its derivatives 1 Cyproterone acetate 1 Diethylstilbestrol and its derivatives 1 Drostanolone and its derivatives 1 Enestebol 1 Ephedrine and its salts (for oral use as a single ingredient) 2 Epinephrine and its salts 1 Epitiostanol 1 Ethylestrenol 1 Fluoxymesterone 1 Folic acid in oral dosage form containing more than 1.0 mg of folic acid per dosage form or, where the largest recommended daily dosage shown on the label would, if consumed by a person, result in the daily intake by that person of more than 1.0 mg of folic acid I Formebolone 1 Furazabol 1 Ilalofantrine 2 Ilydroquinone (topical preparations in concentrations of 2% or more) 1 4-11ydroxy-19-nortestosterone and its derivatives 1 Mebolazine 1 Megestrol and its derivatives Mesabolone 1 Mesterolone 1 Metandienone 1 Metenolone and its derivatives 1 Methandriol 1 Methyltestosterone and its derivatives 1 Metribolone 1 Mibolerone 1 Nandrolone and its derivatives 1 Norboletone 1 Norclostebol and its derivatives 1 Norethandrolone Prescription not required if sold tier veterinary use, provided that the product is labelled by the manufacturer "for agricultural use only or "fir veterinary use only."

1 Nystatin and its salts and derivatives (except vaginal preparations or preparations for topical use on the skin ) 3 Nystatin and its salts and derivatives (vaginal or topical preparations for use on the skin) 1 Oxabolone and its derivatives 1 Oxandrolone Oxymesterone 1 Oxymetholone 1 Pancreatic enzymes 1 Pancreatin 1 Pancrelipase 2 Papain (as debriding agent) 2 Potassium salts (preparations containing more than 5 mmol per single dose) 1 Prasterone 1 Quinbolone 1 Stanozolol 1 Stenbolone and its derivatives 1 Testosterone and its derivatives 1 Tibolone 1 Tiomesterone 1 Trenbolone and its derivatives 1 Vitamin K And by the addition of, in alphabetical order: 3 Acetaminophen (in sustained-release formulations) 1 Diethylstilbestrol and its salts and derivatives' 1 Ephedrihe and its salts (in preparations containing more that 11 mg per single dose and 32.5 mg per recommended daily dose, and if indicated for other than nasal congestion) 1 Epinephrine and its salts (other than in pre-filled syringes intended for emergency administration by injection in the event of anaphylactic reactions to allergens) 2 Epinephrine and its salts (in pre-filled syringes intended for emergency administration by injection in the event of anaphylactic reactions to allergens) 1 Folk acid (in preparations containing more than 1.0 mg of folic acid per dosage form or, where the largest recommended daily dosage shown on the label would, if consumed by a person, result in the daily intake by that person of more than 1.0 mg of folic acid) 1 I lalofantrine and its salts Ilydroquinone (topical preparations) 1 Megestrol and its salts 1 Nalmefene and its salts 1 Nystatin and its salts and derivatives' (except preparations for topical use on the skin) 3 Nystatin and its salts and derivatives (in topical preparations for use on the skin) 1 Olanzapine and its salts 1 Pancreatic enzymes (in products for the treatment of established pancreatic insufficiency) 1 Pancreatin (in products for the treatment of established pancreatic insufficiency) Prescription not required if sold for veterinary use. provided that the product is labelled by the manufacturer "for agricultural use only - or - for veterinary use onl.v."

1 Pancrelipase (in products for the treatment of established pancreatic insufficiency) 2 Potassium salts (oral preparations containing more than 5 mmol per single dose) I Potassium salts (in preparations for injection) 1 Vitamin IC Prescription not required if sold for veterinary use, provided that the product is labelled by the manufacturer "for agricultural use only or "for veterinary use only."

Resolution of the Council of the College of Pharmacists of British Columbia ("the Council"), made at Vancouver, British Columbia, the 26th day of November 1999. RESOLVED THAT: In accordance with the authority established in

Section 64 of The Pharmacists, Pharmacy Operations and Drug Scheduling Act, R.S.B.C. 1996, c. 363 of British Columbia, the Council amends the Drug Schedules Regulation as set out in the attached schedule, subject to the approval of the Lieutenant Governor in Council. Certified a true copy drA_ Linda Lytle, B.Sc.(Phr.), R.Ph., CAE Registrar 4 oteu- I 5/tmd 26 NOV 49 PRI SCI I RF(i IX)C

SCHEDULE That, effective immediately, the Drug Schedules Regulation be amended by the deletion of: 3 Acetaminophen (except in packages containing less than 25 dosage units containing 325 mg or less per dosage unit) 2 Allergy serums 3 Electrolyte solutions (for oral rehydration) 2 Electrolyte solutions (except in oral rehydration preparations) 2 Epinephrine and its salts 2 Iodinated caseine 2 Mupirocin 1 Oxiconazole and its salts 2 Papain (as debriding agent) 2 Pinaverium and its salts (except pinavenun:',romide) 2 Quinine salts 1 Tilmicosin And by the addition of, in alphabetical order: 1 Abacavir and its salts 1 Allergy serums 1 Ancestim 1 Celecoxib and its salts 1 Citalopram and its salts 1 Amino acid solutions (for parenteral use) 1 Electrolyte solutions (for parenteral use) 2 Epinephrine and its salts (intended for emergency administration by injection in the event of anaphylactic reactions to allergens) 1 Epinephrine and its salts (other than in preparations intended for emergency injection in the event of anaphylactic reactions to allergens) 1 Eprosartan and its salts and derivatives 1 Eptilibatide and its salts 1 Methacholine chloride 1 Mupirocin 1 Orlistat 1 Quinine salts 1 Rizatriptan and its salts 1 Tilmicosin 1 Tilmicosin when sold or recommended for administration by the oral route oteu- I 5/tmd 26 NOV 99 1)1016 SCI I Rli(i.DOC

APPENDIX A B.C. Reg. 9/98 Deposited January 9, 1998 O.C. 35/98 Pharmacists, Pharmacy Operations and Drug Scheduling Act DRUG SCHEDULES REGULATION (includes amendments up to B.C. Reg. 247/991 Contents I Alphabetical order 2 Sale of drugs 3 Repealed SCHEDULES Alphabetical order 1

(1) The drug schedules are printed in an alphabetical format to simplify the process of locating each individual drug entry anii determining its status in British Columbia.

(2) Each entry is preceded by a code noted as 1, 1 A, 2 or 3, in which 1 =

Schedule I 1 A = Triplicate/Duplicate Prescription Program 2 =

Schedule II 3 =

Schedule III Sale of drugs 2

(1) Drugs listed in Schedules I, IA, II and 111 must be sold from licensed pharmacies.

(2) Unscheduled drugs may be sold from non-pharmacy outlets.

(3) The various schedules are differentiated as follows:

Schedule I (Prescription):

Schedule I drugs require a prescription for sale and are provided to the public by a pharmacist following the diagnosis and professional intervention of a practitioner. The sale is controlled in a regulated environment as defined by provincial pharmacy legislation. Entries followed by a "V" superscript may be sold without having received a prescription it (

a) the drug is in a form not suitable for human use, or (

b) the main panel of both the inner label and the outer label carries, in both official languages, the statement "For Veterinary Use Only" or "Veterinary Use Only" immediately following or preceding the brand name, proper name or common name, in type size not less than one-half as large as the largest type on the label.

Schedule IA (Triplicate/Duplicate Prescription Program): Drugs which may be sold by a pharmacist to a practitioner or on the prescription of a practitioner in accordance with

Section B-19 (16) of the bylaws to the Pharmacists, Pharmacy Operations and Drug Scheduling Act. November 12, 1999 1

PHARMACISTS, PHARMACY OPERATIONS AND DRUG SCHEDULING ACT B.C. Reg. 9/98 DRUG SCHEDULES REGULATION Schedules

Schedule 11 (Professional Service Area): Drugs which may he sold by a pharmacist on a nonprescription basis and which must be retained within the Professional Service Area of the pharmacy where there is no public access and no opportunity for patient self-selection.

Schedule 113 (Professional Products Area): Drugs which may be sold by a pharmacist to any person from the self-selection Professional Products Area of a licensed pharmacy. Unscheduled (Nonpharmacy Sale): Drugs which may be sold by a nonphar- macist to any person. Combination products 3 Repealed. (B.C. Reg. 418/98.1 SCHEDULES (am. B.C.

Regs. 9/98; 141/98; 418/98; 247/99.1 1 Abciximab 1 Acarbose and its derivatives 1 Acebutolol and its salts 1 Acepromazine and its salts v 3 Acetaminophen (except in packages containing less than 25 dosage units containing 325 mg or less per dosage unit) 1 Acetanilide v 2 Acetarsol 1 Acetazolamide 1 Acetohexamide 1 Acetylcarbromal 1 Acetylcholine Chloride 2 Acetylcysteine 1 Acetylsalicylic acid and its salts (in oral preparations containing 80 mg or less per dosage unit in containers with more than 24 dosage units per container) 2 Acetylsalicylic acid and its salts (in oral preparations containing 80 mg or less per dosage unit in child-resistant containers with 24 or less dosage units per container or rectal preparations containing 150 mg or less per dosage unit) 3 Acetylsalicylic acid and its salts (except in packages containing less than 51 dosage units of 325 mg or less per dosage unit) 1 Acitretin and its salts and derivatives 1 Aconiazide and its salts 3 Acyclovir and its salts (in topical preparations in concentrations of 5% or less) 1 Acyclovir and its salts (except in topical preparations in concentrations of 5% or less) v Prescription not required if sold for veterinary use, provided that the product is labelled by the manufacturer "for agricultural use only" or "for veterinary use only" 2 November 12, 1999

Document details

Collection	British Columbia — Orders in Council
Citation	O.C. 1627/2000
Type	order_in_council
Volume / chapter	arc oic 1627 2000
Language	en
Format	pdf
Source	PROVINCIAL
Identifier	b0979472b95de8082e638cf12cbe0620222ec677

Source file is stored in the law ingest library (pdf).